Manufacturer with High Quality and Competitive Price
Commercial Supply Aliskiren Related Intermediates:
Aliskiren CAS: 173334-57-1
Aliskiren Hemifumarate CAS: 173334-58-2
(S)-4-Benzyl-2-Oxazolidinone CAS: 90719-32-7
(R)-4-Benzyl-2-Oxazolidinone CAS: 102029-44-7
trans-1,4-Dibromo-2-Butene CAS: 821-06-7
Isovaleryl Chloride CAS: 108-12-3
D-Phenylalanine CAS: 673-06-3
D-Phenylalaninol CAS: 5267-64-1
Chemical Name |
(R)-4-Benzyl-2-Oxazolidinone |
Synonyms |
R-BOZ |
CAS Number |
102029-44-7 |
CAT Number |
RF-PI148 |
Stock Status |
In Stock, Production Scale Up to Tons |
Molecular Formula |
C10H11NO2 |
Molecular Weight |
177.2 |
Melting Point |
88.0~90.0℃ |
Density |
1.1607 |
Brand |
Ruifu Chemical |
Item |
Specifications |
Appearance |
White Powder |
Purity / Analysis Method |
≥98.0% (HPLC) |
Specific Rotation |
+14.0° ~ +15.0° (C=5, MeOH) |
Melting Point |
87.0℃~90.0℃ |
Moisture (K.F) |
≤0.50% |
Test Standard |
Enterprise Standard |
Usage |
Aliskiren (CAS: 173334-57-1) Intermediate; Chiral Compounds |
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Manufacturer with High Quality and Competitive Price
(S)-4-Benzyl-2-Oxazolidinone CAS: 90719-32-7
(R)-4-Benzyl-2-Oxazolidinone CAS: 102029-44-7
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (R)-4-Benzyl-2-Oxazolidinone (CAS: 102029-44-7) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and active pharmaceutical ingredient (API) synthesis. It can be used in the synthesis of Aliskiren (CAS: 173334-57-1).
(R)-4-Benzyl-2-Oxazolidinone (CAS: 102029-44-7) is an oxazolidinone used in chiral auxiliary asymetric synthesis, can be used in the enantioselective synthesis of beta-lactams and alpha-amino acids. End products can include asysmmetric single isomeric drugs of antitumor, anesthetic, antipasmodic products. Used in the synthesis of HIV protease inhibitors.